Pharma & Biotech

NRx Pharmaceuticals is bolstering its executive team with a strategic hire aimed at accelerating the development of novel neuroplastic treatments....

Eterna Therapeutics has drawn significant market attention following a substantial insider purchase and the release of an updated corporate strategy....

The story of Danimer Scientific, once a celebrated pioneer in bioplastics, has reached its definitive conclusion on the public markets....

The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...

The clinical development pipeline at Avenue Therapeutics is progressing, with recent strategic moves placing several drug candidates in the spotlight....

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

Axsome Therapeutics is embarking on a significant commercial and regulatory push. The biopharmaceutical company aims to solidify its position in...

A significant legal challenge has been resolved in favor of Abbott Laboratories. This week, a U.S. federal court issued a...